Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Vaccines

PUBLISHER: TechSci Research | PRODUCT CODE: 1266843

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1266843

Digital Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

PUBLISHED:
PAGES: 178 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF and Excel (Multi-User License)
USD 5900
PDF and Excel (Custom Research License)
USD 8900

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Description

Table of Contents

List of Tables

Global Digital Vaccine Market is projected to witness impressive growth during the forecast period. Global digital vaccine market stood at USD 1534.07 million in 2022 and is expected to register a CAGR of 10.66% and reach USD 2779.10 million by 2028. The goal of Digital Vaccine is to change behavior patterns and enhance both mental and physical health by employing neurocognitive training and nudging tactics. A digital vaccination is a tool that trains the brain and encourages good habits using a variety of digital technologies, such as virtual reality, smartphone apps, and artificial intelligence. Moreover, digital vaccines are cutting-edge technologies that can aid individuals in enhancing their mental health and encouraging positive behavior. They are affordable, simple to use, and adaptable to different demands. Also, they have the ability to help where it is most needed and reach a huge audience. Digital vaccinations hold great promise for enhancing mental health and encouraging good conduct in people. These vaccinations have the ability to assist people in forming healthier behaviors and leading better, more meaningful lives by combining neurocognitive training and nudging strategies. The potential for digital vaccines to promote positive change is enormous and exciting as digital technologies continue to develop.

Digital vaccines have undergone a revolution as a result of the booming healthcare IT market and the development of cutting-edge ideas like the Internet of Things (IoT), wearable technology, metaverse platforms, and augmented reality (AR/VR). These innovations are allowing for much more frequent behavioral interventions to treat a wide range of diseases and phobias. For instance, the National Center for Telehealth and Technology (T2) of the US Department of Defense has created a computer application called Virtual PTSD Experience which is based on the internationally populated virtual world called second life. In this virtual reality video game, military soldiers can create a virtual avatar to play through scenarios that are realistic and help with mental health issues. Further, in order to increase the effectiveness and precision of needle-free vaccines in treating patients for various diseases or phobias, artificial intelligence, and machine learning are being employed more and more in digital vaccine management systems. Moreover, AI and machine learning can aid in the creation of video games and mobile applications that encourage youngsters to adopt healthy eating habits and active lifestyles. Avatars powered by AI is also the foundation of the first digital vaccine to be granted a US patent.

Growing Prevalence of Diseases

Non-communicable diseases (NCDs) impact people from all age groups, geographical areas, and nations. Although these illnesses are frequently linked to older age groups, statistics show that 17 million deaths from Non-communicable diseases (NCDs) happen before the age of 70. According to estimates, 86% of these early fatalities take place in low- and middle-income nations, owing to a lack of awareness and availability of digital technologies. As per World Health Organization (WHO), non-communicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally, which is expected to boost the demand for digital vaccines throughout the forecast period.

Additionally, children, adults, and seniors are susceptible to the risk factors for Non-communicable diseases (NCDs), including poor diets, inactivity, exposure to tobacco smoke, and problematic alcohol use, which in turn is driving the demand for digital vaccines to adopt healthy eating habits or lifestyle among individuals. Further, the prevalence of various diseases such as diabetes, cancer, and cardiovascular diseases, among others, which can be managed by adopting a healthy eating habit or lifestyle, is expected to increase the demand for products such as digital vaccines. For instance, cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including kidney disease deaths caused by diabetes). Hence, with the help of tablets, smartphones, and other such devices, Digital Vaccine hopes to deliver healthcare. It aids in reducing disease risk, symptom severity, and hospitalization of patients with any diseases.

Focus on Personalized Medicine

One of the most promising methods for combating diseases, especially in case of diseases lacking any kind of potential treatment, is precision medicine, often known as personalized medicine. People, families, and entire civilizations suffer greatly as a result of cancer, neurological illnesses, and unusual genetic abnormalities. Due to greater patient response and the maximum safety margin to assure better patient care, personalized medicines have recently grown in favor among healthcare professionals. The potential for improved healthcare, even at a cheaper cost, is shown by personalized therapeutics. The patient can benefit from an early diagnosis, risk management, and the best possible care. Moreover, an increasing tendency that aimed to provide patients with personalized care gave rise to personalized medicine, which led to the growth of the digital vaccine market. Further, the use of digital biomarkers to define more exact outcome measures and clinical research objectives is becoming more and more important. They can involve voice-recorded mood and disease progression, cognitive exams performed as games on tablets, and actigraphy. Hence, rising awareness and focus on personalized medicines drive the growth of digital vaccines throughout the forecast period.

Increase in Clinical Trials and Patents of Digital Vaccines

The demand for digital vaccines has grown dramatically over time as a result of rising knowledge about them and their advantages in the treatment of various diseases and phobias. In turn, this has considerably boosted the amount of research and development being done on digital vaccinations, which has raised the number of clinical studies being conducted around the world. Also, many people are keen to engage in clinical studies for digital vaccinations, which will support market expansion through 2028. Further, rising patents of digital vaccines are expected to support the growth of the market. For instance, Vydiant Inc. filed a patent on 25 March 2022; titled "A Digital Vaccine System, Method and Device." A collection of tuples that affect a pathogen's risk of causing infection which is saved on a non-transitory computer-readable device known as a pathogen knowledge base. The Digital Vaccine System's assessment of a pathogen risk and delivery of pathogen risk recommendations to one or more users, is based on an infection risk value that indicates the probability of a user having the pathogen parameter. Moreover, Haddad Alias also filed the patent for cybercriminal activity of a digital vaccine app on 19 September 2017 and got published it on 19 October 2021, titled "Enhanced Computer Objects Security." Hence, increasing clinical trials and patents on digital vaccines are fueling market expansion and awareness among individuals.

Data Privacy and Security Concerns to Hamper the Growth of the Market

Confidentiality of patient data is stored in digital vaccine management systems, so protecting the privacy and security of this information is of utmost importance. Hacking, data breaches, and unauthorized access to this sensitive information are worries. This is a significant worry that prevents individuals from adopting many digital vaccine solutions. Furthermore, the lack of consistent internet and electronic device connectivity makes it challenging to apply digital vaccine management systems efficiently in many parts of the world. Also, a lack of knowledge about cutting-edge solutions like digital vaccinations among the populace, particularly in developing and emerging nations, may hinder the expansion of the global market for digital vaccines.

Market Segmentation

The Global Digital Vaccine Market is segmented based on device type and application. Based on device type, the market is divided into smartphones, tablets, and others. Based on application, the market is categorized into Diabetes, Infectious Diseases, Cardiovascular Diseases, and Others.

Market players

FriendsLearn, Inc., Klein Buendel, Inc, Evidation Health, Inc., Atos SE, oVRcome.

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Digital Vaccine Market, By Device Type:

  • Smartphones
  • Tablets
  • Others

Global Digital Vaccine Market, By Application:

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Global Digital Vaccine Market, By Region:

  • Asia-Pacific
    • India
    • Australia
    • China
    • Japan
    • Thailand
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Denmark
    • Germany
  • Middle East & Africa
    • Saudi Africa
    • Nigeria
    • UAE
    • Saudi Arabia
  • South America
    • Argentina
    • Brazil
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Show more
Product Code: 12817

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Digital Vaccine Market

5. Clinical Trial Analysis

6. Patent Analysis

7. Voice of Customer

8. Global Digital Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type (Smartphones, Tablets, Others)
    • 8.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 8.2.3. By Region
    • 8.2.4. By Company (2022)

9. Asia-Pacific Digital Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type (Smartphones, Tablets, Others)
    • 9.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Digital Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Australia Digital Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Application
    • 9.3.3. China Digital Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Application
    • 9.3.4. Japan Digital Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Device Type
        • 9.3.4.2.2. By Application
    • 9.3.5. Thailand Digital Vaccine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Device Type
        • 9.3.5.2.2. By Application

10. North America Digital Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type (Smartphones, Tablets, Others)
    • 10.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 10.2.3. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Digital Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Canada Digital Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Mexico Digital Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Application

11. Europe Digital Vaccine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Device Type (Smartphones, Tablets, Others)
    • 11.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 11.2.3. By Country
  • 11.3. Europe: Country Analysis
    • 11.3.1. France Digital Vaccine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Device Type
        • 11.3.1.2.2. By Application
    • 11.3.2. United Kingdom Digital Vaccine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Device Type
        • 11.3.2.2.2. By Application
    • 11.3.3. Italy Digital Vaccine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Device Type
        • 11.3.3.2.2. By Application
    • 11.3.4. Denmark Digital Vaccine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Device Type
        • 11.3.4.2.2. By Application
    • 11.3.5. Germany Digital Vaccine Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Device Type
        • 11.3.5.2.2. By Application

12. Middle East and Africa Digital Vaccine Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Device Type (Smartphones, Tablets, Others)
    • 12.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 12.2.3. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Digital Vaccine Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Device Type
        • 12.3.1.2.2. By Application
    • 12.3.2. Nigeria Digital Vaccine Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Device Type
        • 12.3.2.2.2. By Application
    • 12.3.3. UAE Digital Vaccine Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Device Type
        • 12.3.3.2.2. By Application
    • 12.3.4. Saudi Arabia Digital Vaccine Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Device Type
        • 12.3.4.2.2. By Application

13. South America Digital Vaccine Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Device Type (Smartphones, Tablets, Others)
    • 13.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 13.2.3. By Country
  • 13.3. South America: Country Analysis
    • 13.3.1. Argentina Digital Vaccine Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Device Type
        • 13.3.1.2.2. By Application
    • 13.3.2. Brazil Digital Vaccine Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Device Type
        • 13.3.2.2.2. By Application
    • 13.3.3. Colombia Digital Vaccine Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Device Type
        • 13.3.3.2.2. By Application

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

  • 15.1. Product Launches
  • 15.2. Mergers & Acquisitions
  • 15.3. Technological Advancements

16. Global Digital Vaccine Market: SWOT Analysis

17. Competitive Landscape

  • 17.1. FriendsLearn, Inc.
  • 17.2. Klein Buendel, Inc
  • 17.3. Evidation Health, Inc.
  • 17.4. Atos SE
  • 17.5. oVRcome

18. Strategic Recommendation

19. About Us & Disclaimer

Show more
Product Code: 12817

List of Figures

  • Figure 1: Global Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 3: Global Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 4: Global Digital Vaccine Market Share, By Region, By Value, 2018-2028F
  • Figure 5: Global Digital Vaccine Market Map, By Device Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 6: Global Digital Vaccine Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 7: Global Digital Vaccine Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 8: Asia Pacific Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 9: Asia Pacific Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 10: Asia Pacific Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 11: Asia Pacific Digital Vaccine Market Share, By Country, By Value, 2018-2028F
  • Figure 12: India Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 13: Share of Respondents with Diabetes across India (%), 2018-2021
  • Figure 14: India Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 15: India Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 16: Australia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 17: Australia Diabetes Estimates in People of Age Group 20-79 Years (in Thousands)
  • Figure 18: Australia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 19: Australia Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 20: China Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 21: Percentage of New Cancer Cases in China, Both Sexes, All Ages, 2020
  • Figure 22: China Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 23: China Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 24: Japan Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 25: Japan Research & Development Expenditure As a Percentage of GDP, 2017-2020
  • Figure 26: Japan Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 27: Japan Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 28: Thailand Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 29: People with Diabetes in Thailand, in 1,000s
  • Figure 30: Thailand Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 31: Thailand Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 32: North America Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 33: North America Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 34: North America Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 35: North America Digital Vaccine Market Share, By Country, By Value, 2018-2028F
  • Figure 36: United States Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 37: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 38: United States Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 39: United States Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 40: Canada Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 41: Total Health Research Expenditure in Canada (USD), 2017-2021
  • Figure 42: Canada Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 43: Canada Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 44: Mexico Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 45: People with Diabetes in Mexico, in 1,000s
  • Figure 46: Mexico Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 47: Mexico Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 48: Europe Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 49: Europe Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 50: Europe Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 51: Europe Digital Vaccine Market Share, By Country, By Value, 2018-2028F
  • Figure 52: France Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 53: Share of the French population who developed depressive symptoms in May 2020, by gender
  • Figure 54: France Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 55: France Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 56: United Kingdom Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 57: Anxiety Levels of People in United Kingdom
  • Figure 58: United Kingdom Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 59: United Kingdom Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 60: Italy Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 61: Number of Individuals Suffering from Diabetes in Italy, 2017-2020 (In Thousands)
  • Figure 62: Italy Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 63: Italy Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 64: Denmark Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 65: Number of Individuals Suffering from Type 2 Diabetes in Denmark, 2018-2021
  • Figure 66: Denmark Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 67: Denmark Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 68: Germany Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 69: Germany Research & Development Expenditure as a Percentage of GDP
  • Figure 70: Germany Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 71: Germany Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 72: Middle East & Africa Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 73: Middle East & Africa Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 74: Middle East & Africa Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 75: Middle East & Africa Digital Vaccine Market Share, By Country, By Value, 2018-2028F
  • Figure 76: South Africa Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 77: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
  • Figure 78: South Africa Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 79: South Africa Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 80: Nigeria Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 81: People with Diabetes in Nigeria, in 1,000s
  • Figure 82: Nigeria Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 83: Nigeria Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 84: UAE Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 85: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
  • Figure 86: UAE Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 87: UAE Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 88: Saudi Arabia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 89: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
  • Figure 90: Saudi Arabia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 91: Saudi Arabia Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 92: South America Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 93: South America Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 94: South America Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 95: South America Digital Vaccine Market Share, By Country, By Value, 2018-2028F
  • Figure 96: Argentina Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
  • Figure 98: Argentina Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 99: Argentina Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 100: Brazil Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 101: People with Diabetes in Brazil, in 1,000s
  • Figure 102: Brazil Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 103: Brazil Digital Vaccine Market Share, By Application, By Value, 2018-2028F
  • Figure 104: Colombia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
  • Figure 105: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
  • Figure 106: Colombia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
  • Figure 107: Colombia Digital Vaccine Market Share, By Application, By Value, 2018-2028F

List of Tables

  • Table 1: Digital Vaccine, Clinical Trial Analysis
  • Table 2: Global Cancer Statistics, 2020
  • Table 3: Asia Pacific Cancer Statistics, 2020
  • Table 4: North America Cancer Statistics, 2020
  • Table 5: Europe Cancer Statistics, 2020
  • Table 6: Middle East & Africa Cancer Statistics, 2020
  • Table 7: South America Cancer Statistics, 2020
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!